Claritas Pharmaceuticals Financial Health
How is Claritas Pharmaceuticals's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CLAS's short term assets ($11.0M) exceed its short term liabilities ($7.7M).
Long Term Liabilities: CLAS's short term assets ($11.0M) exceed its long term liabilities ($10.0K).
Debt to Equity History and Analysis
Debt Level: CLAS's net debt to equity ratio (16.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if CLAS's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CLAS's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: CLAS's interest payments on its debt are not well covered by EBIT (0.2x coverage).